<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-28T20:32:56Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/110934" metadataPrefix="rdf">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/110934</identifier><datestamp>2025-03-18T12:38:04Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:docta.ucm.es:20.500.14352/110934">
      <dc:title>Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties</dc:title>
      <dc:creator>Herrera Arozamena, C.</dc:creator>
      <dc:creator>Estrada Valencia, M</dc:creator>
      <dc:creator>García Díez, G.</dc:creator>
      <dc:creator>Pérez, C.</dc:creator>
      <dc:creator>León, R.</dc:creator>
      <dc:creator>Infantes, L.</dc:creator>
      <dc:creator>Morales García, José Ángel</dc:creator>
      <dc:creator>Pérez Castillo, Ana</dc:creator>
      <dc:creator>Sastre, E. del</dc:creator>
      <dc:creator>López, M.G.</dc:creator>
      <dc:creator>Rodríguez Franco, M.I.</dc:creator>
      <dc:description>5-Methoxy-3-(5-methoxyindolin-2-yl)-1H-indole (3), whose structure was unambiguously elucidated by X-ray analysis, was identified as a multi-target compound with potential application in neurodegenerative diseases. It is a low nanomolar inhibitor of QR2 (IC50 = 7.7 nM), with greater potency than melatonin and comparable efficacy to the most potent QR2 inhibitors described to date. Molecular docking studies revealed the potential binding mode of 3 to QR2, which explains its superior potency compared to melatonin. Furthermore, compound 3 inhibits hMAO-A, hMAO-B and hLOX-5 in the low micromolar range and is an excellent ROS scavenger. In phenotypic assays, compound 3 showed neuroprotective activity in a cellular model of oxidative stress damage, it was non-toxic, and was able to activate neurogenesis from neural stem-cell niches of adult mice. These excellent biological properties, together with its both good in silico and in vitro drug-like profile, highlight compound 3 as a promising drug candidate for neurodegenerative diseases.</dc:description>
      <dc:date>2024-11-22T07:55:58Z</dc:date>
      <dc:date>2024-11-22T07:55:58Z</dc:date>
      <dc:date>2024</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Herrera-Arozamena C, Estrada-Valencia M, García-Díez G, Pérez C, León R, Infantes L, Morales-García JA, Pérez-Castillo A, Del Sastre E, López MG, Rodríguez-Franco MI. Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties. Eur J Med Chem. 2024 Nov 5;277:116763. doi: 10.1016/j.ejmech.2024.116763. Epub 2024 Aug 10. PMID: 39146834.</dc:identifier>
      <dc:identifier>10.1016/J.EJMECH.2024.116763</dc:identifier>
      <dc:identifier>https://hdl.handle.net/20.500.14352/110934</dc:identifier>
      <dc:identifier>https://doi.org/10.1016/j.ejmech.2024.116763</dc:identifier>
      <dc:identifier>https://www.sciencedirect.com/science/article/pii/S0223523424006445?via%3Dihub</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   </ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>